CHXPreventsSerumWithdrawal-InducedApoptosis
1439
Fig.3.CHXblocksp53activationandcellcyclearrestinducedbyserumdeprivation.A,HepG2cellswereculturedinserum-freemediumwithorwithout10 MCHXfor8,16,and24h.Cellsculturedin10%serumcontainingmediumforthesametimepointswereusedascontrol.Celllysateswerepreparedbysonicatingcellsfollowedbycentrifugation.Totalp53,phosphory-lated(pSer-15)p53,p21,andBaxlevelswereevalu-atedbyWesternblotanalysisusingrespectiveanti-bodyagainstp53,phosphorylated(pSer-15)p53,p21,andBax.B,HepG2cellswereincubatedwithmediumcontaining10%serumornoseruminthepresenceorabsenceof10 MCHXfor16h.CellswereharvestedandpreparedforcellcycleanalysisasdescribedunderMaterialsandMethods.a,flowcytometryDNAhisto-graphsofcellstreatedwithcompleteserumcontainingmedium(control),serumcontainingmediumplusCHX(CHX),serum-freemedium(SW),andserum-freeme-diumplusCHX.b,percentageofcellsindifferentstagesofG0andG1,S-G2,andMwerequantified,anddataarethemeanoftwoindependentexperiments.
neocells.Cellviabilitieswerearound80%inHepG2-mtp53cellsandHep3Bcellscomparedwith38%inHepG2-neocontrolcells(Fig.4Bb),andmorphologicalchangesasshowninFig.4CbconfirmthelackoftoxicityintheHepG2-mtp53andHep3Bcellssubjectedtoserumwithdrawal.
siRNALoweringofp53ProtectsHepG2CellsfromSerumWithdrawal-InducedCellDeath.Tofurthereval-uatetheroleofp53inthetoxicityinducedbyserumdepri-vation,siRNA-p53andsiRNA-control(anontargetingsiRNA)weretransfectedintoHepG2cells.Twenty-fourhoursaftertransfection,cellswereculturedinmediumwithorwithoutserumforanadditional24h.p53andpp53aswellasBaxlevelswereevaluatedbyWesternblotanalysisasshowninFig.5A.Thetotalp53andBaxlevelsinHepG2cellstransfectedwithp53siRNAdramaticallydecreasedcom-paredwithcellstransfectedwithcontrolsiRNA.Serumde-privationincreasedpp53andBaxlevelsinHepG2cellstransfectedwithcontrolsiRNAbutnotincellstransfectedwithp53siRNA(Fig.5A).Cellviabilityevaluatedafterse-rumdeprivationfor48hwashigherincellstransfectedwithsiRNA-p53comparedwithcellstransfectedwithsiRNA-con-trol(62versus39%,p 0.05)(Fig.5B).
CHXDecreasesp53Accumulationandp53Phos-phorylationInducedbyActD,Doxorubicin,andEto-poside.TofurtherstudyhowCHXinhibitsp53activationandlevelsofp53,HepG2cellsweretreatedwiththerapeuticreagents2.5 MActD,2.5 Mdoxorubicin,and25 Meto-posidewithorwithout10 MCHXfor16h.Totalp53andpp53(Ser-15)levelswereevaluatedbyWesternblot.Thesethreereagentsinducetotalp53andpp53levelscomparedwithcontrol.CHXblockedthiselevationoftotalp53andpp53(Fig.6),showingthatloweringofp53levelsandacti-vationofp53topp53byCHXisnotlimitedtoonlytheserumwithdrawalmodel.
TheCHXDecreaseofp53AccumulationIsRelatedtop53PhosphorylationbutNottopp53Dephosphoryla-tion.p53accumulationcausedbyDNA-damagingreagentsismainlyduetoposttranslationalmodificationssuchas

p53
cycloheximide, or TNF-a (Wang et al., 1999; ...and hepatocellular carcinoma HepG2 cells transduced ...Activated YSK1 phosphorylated 14-3-3 and ...
and phosphorylated p70S6K by PQIP in 3T3/ huIGF1R...IR was 261 nmol/L in HepG2 cells (Table 2)...In addition, activation of the IGF-IR protects ...
and phosphorylated p70S6K by PQIP in 3T3/ huIGF1R...IR was 261 nmol/L in HepG2 cells (Table 2)...In addition, activation of the IGF-IR protects ...
热门文档